PMID- 16024646 OWN - NLM STAT- MEDLINE DCOM- 20050914 LR - 20210103 IS - 0008-5472 (Print) IS - 0008-5472 (Linking) VI - 65 IP - 14 DP - 2005 Jul 15 TI - Immunoselective pressure and human leukocyte antigen class I antigen machinery defects in microsatellite unstable colorectal cancers. PG - 6418-24 AB - In colorectal cancer, the immune response is particularly pronounced against tumors displaying the high microsatellite instability (MSI-H) phenotype. MSI-H tumors accumulate mutations affecting microsatellites located within protein encoding regions (coding microsatellites, cMS), which lead to translational shifts of the respective reading frames. Consequently, novel tumor-specific frameshift-derived neopeptides (FSP) are generated and presented by MSI-H tumor cells, thus eliciting effective cytotoxic immune responses. To analyze whether the immunoselective pressure was reflected by the phenotype of MSI-H colorectal cancer cells, we compared here the expression of antigen processing machinery (APM) components and human leukocyte antigen (HLA) class I antigen subunits in 20 MSI-H and 20 microsatellite-stable (MSS) colorectal cancer using a panel of newly developed APM component-specific monoclonal antibodies. In addition, we did a systematic analysis of mutations at cMS located within APM genes and beta2-microglobulin (beta2m). Total HLA class I antigen loss was observed in 12 (60.0%) of the 20 MSI-H lesions compared with only 6 (30.0%) of the 20 MSS colorectal cancer lesions. Moreover, total loss of membraneous HLA-A staining was significantly more frequent in MSI-H colorectal cancer (P = 0.0024). Mutations at cMS of beta2m and genes encoding APM components (TAP1 and TAP2) were detected in at least 7 (35.0%) of 20 MSI-H colorectal cancers but in none of the MSS colorectal cancers (P = 0.0002). These data show that defects of HLA class I antigen processing and presentation seem to be significantly more frequent in MSI-H than in MSS colorectal cancer, suggesting that in MSI-H colorectal cancer the immunoselective pressure leads to the outgrowth of cells with defects of antigen presentation. FAU - Kloor, Matthias AU - Kloor M AD - Institute of Molecular Pathology, University of Heidelberg, Germany. FAU - Becker, Christina AU - Becker C FAU - Benner, Axel AU - Benner A FAU - Woerner, Stefan M AU - Woerner SM FAU - Gebert, Johannes AU - Gebert J FAU - Ferrone, Soldano AU - Ferrone S FAU - von Knebel Doeberitz, Magnus AU - von Knebel Doeberitz M LA - eng GR - CA67108/CA/NCI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - Cancer Res JT - Cancer research JID - 2984705R RN - 0 (ATP Binding Cassette Transporter, Subfamily B, Member 2) RN - 0 (ATP Binding Cassette Transporter, Subfamily B, Member 3) RN - 0 (ATP-Binding Cassette Transporters) RN - 0 (Antibodies, Monoclonal) RN - 0 (HLA-A Antigens) RN - 0 (TAP1 protein, human) RN - 0 (beta 2-Microglobulin) RN - 145892-13-3 (TAP2 protein, human) SB - IM MH - ATP Binding Cassette Transporter, Subfamily B, Member 2 MH - ATP Binding Cassette Transporter, Subfamily B, Member 3 MH - ATP-Binding Cassette Transporters/immunology MH - Antibodies, Monoclonal/immunology MH - Antigen Presentation/genetics/immunology MH - Colorectal Neoplasms/*genetics/*immunology MH - HLA-A Antigens/*genetics/*immunology MH - Humans MH - Immunohistochemistry MH - Microsatellite Repeats/genetics/*immunology MH - beta 2-Microglobulin/biosynthesis/genetics/immunology EDAT- 2005/07/19 09:00 MHDA- 2005/09/15 09:00 CRDT- 2005/07/19 09:00 PHST- 2005/07/19 09:00 [pubmed] PHST- 2005/09/15 09:00 [medline] PHST- 2005/07/19 09:00 [entrez] AID - 65/14/6418 [pii] AID - 10.1158/0008-5472.CAN-05-0044 [doi] PST - ppublish SO - Cancer Res. 2005 Jul 15;65(14):6418-24. doi: 10.1158/0008-5472.CAN-05-0044.